The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, producing billions in revenue , its intellectual property lapse created a flood of knock-off medications, significantly diminishing its position . While certain pharmaceutical companies may try to capitalize on male sexua